Intermittent fasting for cardiovascular disease risk factor reduction: A narrative review of current evidence
Background The metabolic syndrome (MetSy), which is defined by the spectrum of obesity, insulin resistance and dyslipidaemia, is recognised as a major contributor to the overall risk of developing cardiovascular disease. Intermittent fasting (IF), which encompasses dieting plans with varying schedu...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Australasian Medical Journal pty ltd.
2018-09-01
|
| Series: | Australasian Medical Journal |
| Subjects: | |
| Online Access: | http://www.amj.net.au/index.php/AMJ/article/viewFile/3485/1696 |